Izotropic Corporation Finalizes Engineering and Development Transition to the United States; Establishes Operations in Primary Target Market
Further to the Company's prior announcement, the move to relocate commercial development of IzoView to Sacramento, CA was made to help accelerate testing and optimization of the device as the Company prepares for its upcoming clinical study and submission for market authorization in the U.S.